We are live on
!
Find out more
TEE
Tibra Equities Europe Portfolio holdings
AUM
$90.4M
1-Year Est. Return
37.81%
This Fund
S&P 500
This Quarter
Est. Return
+2.19%
1 Year Est. Return
+37.81%
3 Year Est. Return
+142.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$811M
AUM Growth
-$542M
(-40%)
Cap. Flow
-$549M
Cap. Flow
% of AUM
-67.7%
Top 10 Holdings %
Top 10 Hldgs %
41.09%
Holding
392
New
163
Increased
21
Reduced
27
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$41.8M |
| 2 |
CELG
Celgene Corp
CELG
|
+$29.5M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$22.1M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$22M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$141M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$47M |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$46.9M |
| 4 |
State Street SPDR Dow Jones REIT ETF
RWR
|
+$46.6M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$42.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.17% |
| 2 | Technology | 15.71% |
| 3 | Healthcare | 15.68% |
| 4 | Industrials | 8.93% |
| 5 | Real Estate | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
176
DELISTED
Veradigm Inc. Common Stock
MDRX
| $324K | 0.04% |
+29,500
| New | +$303K |
|
177
Sally Beauty Holdings
SBH
$1.58B
| $319K | 0.04% |
+21,400
| New | +$280K |
|
178
Healthcare Services Group
HCSG
$1.53B
| $318K | 0.04% |
+13,100
| New | +$331K |
|
179
Ovintiv
OVV
$16.4B
| $316K | 0.04% |
+13,780
| New | +$316K |
|
180
Crocs
CROX
$6.55B
| $314K | 0.04% |
+11,300
| New | +$274K |
|
181
McEwen Inc
MUX
$1.18B
| $313K | 0.04% |
+20,040
| New | +$365K |
|
182
Perdoceo Education
PRDO
$2.12B
| $313K | 0.04% |
+19,700
| New | +$387K |
|
183
Radian Group
RDN
$4.93B
| $313K | 0.04% |
+13,700
| New | +$316K |
|
184
Sunstone Hotel Investors
SHO
$2.06B
| $304K | 0.04% |
+22,100
| New | +$296K |
|
185
Paysign
PAYS
$705M
| $296K | 0.04% |
+29,300
| New | +$390K |
|
186
Bloomin' Brands
BLMN
$938M
| $292K | 0.04% |
+15,400
| New | +$275K |
|
|
MNK
187
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $290K | 0.04% |
+120,300
| New | +$615K |
|
188
Karyopharm Therapeutics
KPTI
$48M
| $282K | 0.03% |
+1,953
| New | +$265K |
|
|
ADVM
189
DELISTED
Adverum Biotechnologies
ADVM
| $265K | 0.03% |
+4,860
| New | +$548K |
|
190
BGC Group
BGC
$4.89B
| $265K | 0.03% |
+48,100
| New | +$258K |
|
|
SAFE
191
Safehold
SAFE
$1.15B
| $265K | 0.03% |
+4,170
| New | +$262K |
|
192
Cleveland-Cliffs
CLF
$6.99B
| $264K | 0.03% |
+36,600
| New | +$330K |
|
|
PDCO
193
DELISTED
Patterson Companies, Inc.
PDCO
| $262K | 0.03% |
+14,700
| New | +$275K |
|
194
PAR Technology
PAR
$735M
| $257K | 0.03% |
+10,800
| New | +$263K |
|
195
Brookdale Senior Living
BKD
$3.4B
| $250K | 0.03% |
+33,000
| New | +$261K |
|
|
BBBY
196
DELISTED
Bed Bath & Beyond Inc
BBBY
| $249K | 0.03% |
+23,400
| New | +$226K |
|
|
ARQL
197
DELISTED
Arqule Inc
ARQL
| $249K | 0.03% |
+34,700
| New | +$326K |
|
198
Darling Ingredients
DAR
$9.44B
| $247K | 0.03% |
+12,900
| New | +$252K |
|
199
Knowles
KN
$3.34B
| $224K | 0.03% |
+11,000
| New | +$216K |
|
200
ATI
ATI
$31B
| $219K | 0.03% |
+10,800
| New | +$228K |
|
Similar funds
EM
BBHBI
EA
SCMU
DCM
BCIMC
LSC
RCM
Tibra Equities Europe's Q3 2019 Portfolio in Review
As of Q3 2019, Tibra Equities Europe held 392 positions worth $811M, down 40% from $1.35B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Tibra Equities Europe withdrew a net $549M in Q3 2019, closing 181 positions and reducing 27 holdings. Its most notable exit was State Street Technology Select Sector SPDR ETF, an estimated $141M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 8.3% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Tibra Equities Europe opened a new position in Allergan plc worth $43.2M.
- Tibra Equities Europe's largest Q3 2019 buy was Allergan plc: 256,514 shares worth $43.2M.
- Tibra Equities Europe added most to Celgene Corp in Q3 2019, an estimated $29.5M increase.
- Tibra Equities Europe's biggest Q3 2019 reduction was iShares Biotechnology ETF, cutting an estimated $47M.
- Tibra Equities Europe fully exited State Street Technology Select Sector SPDR ETF in Q3 2019, selling an estimated $141M.
- Tibra Equities Europe's ten largest holdings make up 41% of its $811M portfolio in Q3 2019.
- Tibra Equities Europe opened 163 new positions and closed 181 in Q3 2019.
- Tibra Equities Europe's portfolio value fell 40% quarter-over-quarter to $811M.
Based on Tibra Equities Europe's 13F filing for Q3 2019, filed 4 Nov 2019.